Literature DB >> 15220194

Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.

Kathrin Maedler1, Joachim Størling, Jeppe Sturis, Richard A Zuellig, Giatgen A Spinas, Per O G Arkhammar, Thomas Mandrup-Poulsen, Marc Y Donath.   

Abstract

Increasing evidence indicates that a progressive decrease in the functional beta-cell mass is the hallmark of both type 1 and type 2 diabetes. The underlying causes, beta-cell apoptosis and impaired secretory function, seem to be partly mediated by macrophage production of interleukin (IL)-1beta and/or high-glucose-induced beta-cell production of IL-1beta. Treatment of type 1 and type 2 diabetic patients with the potassium channel opener diazoxide partially restores insulin secretion. Therefore, we studied the effect of diazoxide and of the novel potassium channel opener NN414, selective for the beta-cell potassium channel SUR1/Kir6.2, on glucose- and IL-1beta-induced apoptosis and impaired function in human beta-cells. Exposure of human islets for 4 days to 11.1 and 33.3 mmol/l glucose, 2 ng/ml IL-1beta, or 10 and 100 micromol/l of the sulfonylurea tolbutamide induced beta-cell apoptosis and impaired glucose-stimulated insulin secretion. The deleterious effects of glucose and IL-1beta were blocked by 200 micromol/l diazoxide as well as by 3 and 30 micromol/l NN414. By Western blotting with phosphospecific antibodies, glucose and IL-1beta were shown to activate the extracellular signal-regulated kinase (ERK) 1/2, an effect that was abrogated by 3 micromol/l NN414. Similarly, 1 micromol/l of the mitogen-activated protein kinase/ERK kinase 1/2 inhibitor PD098059 or 1 micromol/l of the l-type Ca(2+) channel blocker nimodipine prevented glucose- and IL-1beta-induced ERK activation, beta-cell apoptosis, and impaired function. Finally, islet release of IL-1beta in response to high glucose could be abrogated by nimodipine, NN414, or PD098059. Thus, in human islets, glucose- and IL-1beta-induced beta-cell secretory dysfunction and apoptosis are Ca(2+) influx and ERK dependent and can be prevented by the beta-cell selective potassium channel opener NN414.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220194     DOI: 10.2337/diabetes.53.7.1706

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  60 in total

1.  IAPP boosts islet macrophage IL-1 in type 2 diabetes.

Authors:  Thomas Mandrup-Poulsen
Journal:  Nat Immunol       Date:  2010-10       Impact factor: 25.606

Review 2.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 3.  Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

Authors:  Tandy Aye; Jen Block; Bruce Buckingham
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

Review 4.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 5.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

Review 6.  Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.

Authors:  Rebecca J Brown; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2008-01-24       Impact factor: 4.866

7.  Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.

Authors:  Emilyn U Alejandro; James D Johnson
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

8.  The KATP channel is a molecular sensor of atrophy in skeletal muscle.

Authors:  Domenico Tricarico; Antonietta Mele; Giulia Maria Camerino; Roberto Bottinelli; Lorenza Brocca; Antonio Frigeri; Maria Svelto; Alfred L George; Diana Conte Camerino
Journal:  J Physiol       Date:  2010-01-11       Impact factor: 5.182

9.  Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.

Authors:  E-ri M Sol; Tea Sundsten; Peter Bergsten
Journal:  Lipids Health Dis       Date:  2009-02-05       Impact factor: 3.876

10.  Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets.

Authors:  Safia Costes; Brigitte Vandewalle; Cécile Tourrel-Cuzin; Christophe Broca; Nathalie Linck; Gyslaine Bertrand; Julie Kerr-Conte; Bernard Portha; François Pattou; Joel Bockaert; Stéphane Dalle
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.